Skip to main content


Question for Department of Health and Social Care

UIN 17127, tabled on 13 June 2022

To ask the Secretary of State for Health and Social Care, Whether the mAbs drug Beblitovimab is under consideration for purchase by his Department.

This answer is the replacement for a previous holding answer.

Answered on

21 June 2022

The Antivirals and Therapeutics Taskforce is working with the RAPID-C19 Collaborative to review clinical trials data for COVID-19 treatments. Bebtelovimab and other monoclonal antibodies are being reviewed as part of this process. However, Bebtelovimab is not currently under consideration for procurement as it has yet to receive regulatory approval for use in the United Kingdom.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.